Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Weber

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 29, 2023
The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)Bruce Albala, Eline Appelmans, Ramona Burress, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 23, 2025
System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatmentB Joy Snider, Alessandro Biffi, Sasha Bozeat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2025
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 1, 2021
Building clinically relevant outcomes across the Alzheimer's disease spectrumDorene M Rentz, Alette M Wessels, Ananth V Annapragada, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 29, 2025
Amyloid PET and clinical management in a diverse, cognitively impaired population: The New IDEAS StudyCharles C Windon, Constantine Gatsonis, Maria C Carrillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 27, 2026
Differences in amyloid PET positivity based on ethnoracial group and social determinants of health: The new IDEAS studyCorey J Bolton, Peggye Dilworth-Anderson, Jon Steingrimsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2023
Outcome measures for Alzheimer's disease: A global inter-societal Delphi consensusTim S Ellison, Stefano F Cappa, Dawne Garrett, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2021
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tauOskar Hansson, Richard Batrla, Britta Brix, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectivesChristopher J Weber, Maria C Carrillo, William Jagust, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 12, 2022
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivityStephen Zicha, Randall J Bateman, Leslie M Shaw, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 29, 2023
The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)Bruce Albala, Eline Appelmans, Ramona Burress, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 23, 2025
System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatmentB Joy Snider, Alessandro Biffi, Sasha Bozeat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2025
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 1, 2021
Building clinically relevant outcomes across the Alzheimer's disease spectrumDorene M Rentz, Alette M Wessels, Ananth V Annapragada, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 29, 2025
Amyloid PET and clinical management in a diverse, cognitively impaired population: The New IDEAS StudyCharles C Windon, Constantine Gatsonis, Maria C Carrillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 27, 2026
Differences in amyloid PET positivity based on ethnoracial group and social determinants of health: The new IDEAS studyCorey J Bolton, Peggye Dilworth-Anderson, Jon Steingrimsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2023
Outcome measures for Alzheimer's disease: A global inter-societal Delphi consensusTim S Ellison, Stefano F Cappa, Dawne Garrett, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2021
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tauOskar Hansson, Richard Batrla, Britta Brix, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectivesChristopher J Weber, Maria C Carrillo, William Jagust, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 12, 2022
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivityStephen Zicha, Randall J Bateman, Leslie M Shaw, et al.
Pageof 4